Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Measles virus hemagglutinin (MV-H)
- Target
- MV-H
- Molecular classification
- Viral surface glycoprotein, Type II membrane protein, Attachment protein
01
Overview
- Other names
- H proteinHemagglutinin proteinMeasles virus H proteinMV-H protein
02
Biological functions
Viral attachmentReceptor bindingMembrane fusion inductionHemagglutination
03
Disease associations
MeaslesSubacute sclerosing panencephalitis (SSPE)
04
Interacting drugs
Measles vaccine (Live attenuated)
1 more in the full profile.
Beyond the preview
Go deeper on Measles virus hemagglutinin (MV-H).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Measles virus hemagglutinin (MV-H).